A Study of AK0529 in Infants Hospitalized With RSV

Clinical trial NCT02460016 · TERMINATED

Trial details

NCT number: NCT02460016
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2015-08-28
Primary completion: 2015-11-03
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.